- Home
- Test Catalog Search
- 8104B
Share this page
Test Code 8104B
Test Name Postmortem, Fire Death Screen, Blood (Forensic)
Enzyme-Linked Immunosorbent Assay (ELISA)
Headspace Gas Chromatography (GC)
High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)
Spectrophotometry (SP)
1 | Cyanide | CN; Hydrogen Cyanide; Potassium Cyanide | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | mcg/mL | 0.1 | Environmental/Occupation Toxin | |
2 | Opiates | Codeine; Heroin; Morphine; Opium | Enzyme-Linked Immunosorbent Assay (ELISA) | ng/mL | 20 | Narcotic Analgesic | |
3 | Cocaine / Metabolites | Blow; Crack; Snow | Enzyme-Linked Immunosorbent Assay (ELISA) | ng/mL | 20 | Stimulant | |
4 | Benzodiazepines | Sedative; Tranquilizer | Enzyme-Linked Immunosorbent Assay (ELISA) | ng/mL | 100 | Anxiolytic, Sedative | |
5 | Cannabinoids | Cannabis; Hashish; Marihuana; Marijuana; THC | Enzyme-Linked Immunosorbent Assay (ELISA) | ng/mL | 10 | Cannabinoid | |
6 | Amphetamines | Adderall; Amfetamine; Dextroamphetamine; Levoamphetamine | Enzyme-Linked Immunosorbent Assay (ELISA) | ng/mL | 20 | Anorexigenic, Stimulant | |
7 | Barbiturates | Enzyme-Linked Immunosorbent Assay (ELISA) | mcg/mL | 0.04 | Hypnotic, Sedative | ||
8 | Methadone / Metabolite | Enzyme-Linked Immunosorbent Assay (ELISA) | ng/mL | 25 | Narcotic Analgesic | ||
9 | Phencyclidine | Angel Dust; PCP; Sherm | Enzyme-Linked Immunosorbent Assay (ELISA) | ng/mL | 10 | Hallucinogen | |
10 | Buprenorphine / Metabolite | Buprenex®; Suboxone®; Subutex®; Temgesic® | Enzyme-Linked Immunosorbent Assay (ELISA) | ng/mL | 0.5 | Narcotic Analgesic | |
11 | Methamphetamine / MDMA | Desoxyn®; Ecstasy; Meth; Molly | Enzyme-Linked Immunosorbent Assay (ELISA) | ng/mL | 20 | Stimulant | |
12 | Oxycodone / Oxymorphone | Enzyme-Linked Immunosorbent Assay (ELISA) | ng/mL | 10 | Narcotic Analgesic | ||
13 | Fentanyl / Acetyl Fentanyl | Enzyme-Linked Immunosorbent Assay (ELISA) | ng/mL | 0.5 | Anesthetic, Opioid Analgesic | ||
14 | Volatiles | Headspace Gas Chromatography (GC) | Environmental/Occupation Toxin | ||||
15 | Carboxyhemoglobin | COHb | Spectrophotometry (SP) | %Saturation | 5 | Biological Marker (Exposure) |
Reflex Tests
Test Code | Test Name |
---|---|
52167B | Buprenorphine and Metabolite - Free (Unconjugated) Confirmation, Blood |
5636B | Cyanide Confirmation (Qualitative), Blood |
5637B | Cocaine and Metabolites Confirmation, Blood |
5641B | Benzodiazepines Confirmation, Blood |
5643B | Fentanyl and Acetyl Fentanyl Confirmation, Blood |
5645B | Opiates - Free (Unconjugated) Confirmation, Blood |
5646B | Cannabinoids Confirmation, Blood |
5652B | Barbiturates Confirmation, Blood |
5654B | Carbon Monoxide Exposure Biouptake Confirmation, Blood |
5657B | Phencyclidine Confirmation, Blood |
5682B | Methadone and Metabolite Confirmation, Blood |
5684B | Amphetamines Confirmation, Blood |
Studies have shown that cyanide has variable instability in biological specimens and is particularly unstable in some postmortem specimens. The loss of cyanide can be minimized by shipping the sample to the laboratory for analysis as soon as possible, preferably using refrigerated or frozen transportation and preservation using sodium fluoride / potassium oxalate (grey-top tube). Samples should not be refrozen if previously thawed. The potential for increases in cyanide concentrations, although rare, have also been demonstrated and may be due to microbial action. Preservation with sodium fluoride may reduce this possibility.
Additional Collection Instructions
Rejection criteria pertain to clinical sample submissions only.
1 | Cyanide | CN; Hydrogen Cyanide; Potassium Cyanide | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | mcg/mL | 0.1 | Environmental/Occupation Toxin | |
2 | Opiates | Codeine; Heroin; Morphine; Opium | Enzyme-Linked Immunosorbent Assay (ELISA) | ng/mL | 20 | Narcotic Analgesic | |
3 | Cocaine / Metabolites | Blow; Crack; Snow | Enzyme-Linked Immunosorbent Assay (ELISA) | ng/mL | 20 | Stimulant | |
4 | Benzodiazepines | Sedative; Tranquilizer | Enzyme-Linked Immunosorbent Assay (ELISA) | ng/mL | 100 | Anxiolytic, Sedative | |
5 | Cannabinoids | Cannabis; Hashish; Marihuana; Marijuana; THC | Enzyme-Linked Immunosorbent Assay (ELISA) | ng/mL | 10 | Cannabinoid | |
6 | Amphetamines | Adderall; Amfetamine; Dextroamphetamine; Levoamphetamine | Enzyme-Linked Immunosorbent Assay (ELISA) | ng/mL | 20 | Anorexigenic, Stimulant | |
7 | Barbiturates | Enzyme-Linked Immunosorbent Assay (ELISA) | mcg/mL | 0.04 | Hypnotic, Sedative | ||
8 | Methadone / Metabolite | Enzyme-Linked Immunosorbent Assay (ELISA) | ng/mL | 25 | Narcotic Analgesic | ||
9 | Phencyclidine | Angel Dust; PCP; Sherm | Enzyme-Linked Immunosorbent Assay (ELISA) | ng/mL | 10 | Hallucinogen | |
10 | Buprenorphine / Metabolite | Buprenex®; Suboxone®; Subutex®; Temgesic® | Enzyme-Linked Immunosorbent Assay (ELISA) | ng/mL | 0.5 | Narcotic Analgesic | |
11 | Methamphetamine / MDMA | Desoxyn®; Ecstasy; Meth; Molly | Enzyme-Linked Immunosorbent Assay (ELISA) | ng/mL | 20 | Stimulant | |
12 | Oxycodone / Oxymorphone | Enzyme-Linked Immunosorbent Assay (ELISA) | ng/mL | 10 | Narcotic Analgesic | ||
13 | Fentanyl / Acetyl Fentanyl | Enzyme-Linked Immunosorbent Assay (ELISA) | ng/mL | 0.5 | Anesthetic, Opioid Analgesic | ||
14 | Volatiles | Headspace Gas Chromatography (GC) | Environmental/Occupation Toxin | ||||
15 | Carboxyhemoglobin | COHb | Spectrophotometry (SP) | %Saturation | 5 | Biological Marker (Exposure) |
Interface Mapping
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
LOINC® Information
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
The CPT Codes provided in this document are based on AMA Guidelines and are for informational purposes only. NMS Labs Does not assume responsibility for billing errors due to Reliance on the CPT Codes listed in this document.
*The information contained in this document represents database configurations, as they will appear on the effective date listed above.